• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《泌乳素瘤的外科治疗作用》

The Role of Surgery in the Management of Prolactinomas.

机构信息

Department of Neurosurgery, Brigham and Women's Hospital, BTM 4, 60 Fenwood Road, Boston, MA 02115, USA.

Department of Neurosurgery, Brigham and Women's Hospital, BTM 4, 60 Fenwood Road, Boston, MA 02115, USA.

出版信息

Neurosurg Clin N Am. 2019 Oct;30(4):509-514. doi: 10.1016/j.nec.2019.05.010. Epub 2019 Jul 2.

DOI:10.1016/j.nec.2019.05.010
PMID:31471058
Abstract

Prolactinomas are the most common functional pituitary adenoma. Many prolactinomas can be treated with medication, but all patients should be evaluated at a neuroendocrine center including experienced neurosurgeons trained in transsphenoidal surgery. Surgery for prolactinomas is feasible and can be performed with low morbidity. Patients never previously treated with dopamine agonists should be considered for surgery if they have neurologic deficits, pituitary apoplexy, an uncertain diagnosis, or a significantly cystic prolactinoma. Patients previously treated with dopamine agonists should be considered for surgery in cases of intolerance or resistance. Recurrent and aggressive prolactinomas often require multimodal therapy.

摘要

催乳素瘤是最常见的功能性垂体腺瘤。许多催乳素瘤可以通过药物治疗,但所有患者都应在神经内分泌中心进行评估,包括接受过经蝶窦手术培训的经验丰富的神经外科医生。催乳素瘤的手术是可行的,并且可以以低发病率进行。如果患者有神经功能缺损、垂体卒中、不确定的诊断或明显囊性催乳素瘤,则从未接受过多巴胺激动剂治疗的患者应考虑手术。如果患者不耐受或耐药,则应考虑手术治疗。复发性和侵袭性催乳素瘤通常需要多模式治疗。

相似文献

1
The Role of Surgery in the Management of Prolactinomas.《泌乳素瘤的外科治疗作用》
Neurosurg Clin N Am. 2019 Oct;30(4):509-514. doi: 10.1016/j.nec.2019.05.010. Epub 2019 Jul 2.
2
Prolactinoma surgery.泌乳素瘤手术
Ann Endocrinol (Paris). 2007 Jun;68(2-3):118-9. doi: 10.1016/j.ando.2007.03.011. Epub 2007 May 21.
3
Current Status of Surgery in Management of Prolactinomas.催乳素瘤治疗中外科手术的现状
Neurol India. 2020 May-Jun;68(Supplement):S39-S43. doi: 10.4103/0028-3886.287668.
4
The outcome of hypophysectomy for prolactinomas in the era of dopamine agonist therapy.多巴胺激动剂治疗时代泌乳素瘤垂体切除术的结果
Clin Endocrinol (Oxf). 1996 Jun;44(6):711-6. doi: 10.1046/j.1365-2265.1996.738559.x.
5
Management of cystic prolactinomas: a review.囊性泌乳素腺瘤的治疗:综述。
Pituitary. 2018 Aug;21(4):425-430. doi: 10.1007/s11102-018-0888-0.
6
[Pituitary apoplexy in a pregnant woman with cystic microprolactinoma].[患有囊性微泌乳素瘤的孕妇发生垂体卒中]
Endocrinol Nutr. 2015 Apr;62(4):200-2. doi: 10.1016/j.endonu.2015.01.007. Epub 2015 Feb 26.
7
Surgical outcomes in hyporesponsive prolactinomas: analysis of patients with resistance or intolerance to dopamine agonists.反应低下型泌乳素瘤的手术结局:对多巴胺激动剂耐药或不耐受患者的分析
Pituitary. 2005;8(1):53-60. doi: 10.1007/s11102-005-5086-1.
8
Prolactin, prolactin disorders, and dopamine agonists during pregnancy.妊娠期间的催乳素、催乳素紊乱和多巴胺激动剂。
Hormones (Athens). 2019 Jun;18(2):137-139. doi: 10.1007/s42000-018-0071-z. Epub 2018 Oct 19.
9
Management of psychosis associated with a prolactinoma: case report and review of the literature.与泌乳素瘤相关的精神病的管理:病例报告及文献复习。
Psychosomatics. 2010 Sep-Oct;51(5):370-6. doi: 10.1176/appi.psy.51.5.370.
10
Update on prolactinomas. Part 2: Treatment and management strategies.泌乳素瘤最新进展。第2部分:治疗与管理策略。
J Clin Neurosci. 2015 Oct;22(10):1568-74. doi: 10.1016/j.jocn.2015.03.059. Epub 2015 Aug 1.

引用本文的文献

1
miR-21-5p Targets PIK3R1 to Regulate the NF-B Signaling Pathway, Inhibiting the Invasion and Progression of Prolactinoma.微小RNA-21-5p靶向磷脂酰肌醇-3激酶调节亚基1以调控核因子-κB信号通路,抑制催乳素瘤的侵袭与进展。
Int J Endocrinol. 2025 Feb 5;2025:7741091. doi: 10.1155/ije/7741091. eCollection 2025.
2
Predictors of favorable long-term outcomes in first-line surgery for microprolactinomas.微泌乳素瘤一线手术长期良好预后的预测因素
J Neurooncol. 2025 May;172(3):613-623. doi: 10.1007/s11060-025-04958-6. Epub 2025 Feb 4.
3
Outcome Measures for Medical and Surgical Treatment of Prolactinomas. Is the Role of Surgery Underestimated?
催乳素瘤药物及手术治疗的疗效评估。手术的作用是否被低估了?
J Neurol Surg B Skull Base. 2023 Dec 13;86(1):46-57. doi: 10.1055/a-2212-0504. eCollection 2025 Feb.
4
THE PLACE OF SURGERY IN THE MANAGEMENT OF PROLACTIN SECRETING ADENOMAS.手术在泌乳素分泌性腺瘤治疗中的地位
Acta Endocrinol (Buchar). 2024 Jan-Mar;20(1):65-73. doi: 10.4183/aeb.2024.65. Epub 2024 Oct 3.
5
[Modern concepts of genetic and immunohistochemical features of prolactin-secreting pituitary adenomas].[泌乳素分泌型垂体腺瘤的遗传和免疫组化特征的现代概念]
Probl Endokrinol (Mosk). 2023 Jun 30;69(3):44-50. doi: 10.14341/probl13222.
6
Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?多巴胺激动剂治疗泌乳素瘤:我们是否需要重新思考手术在泌乳素瘤管理中的地位?
Endocr Oncol. 2022 Apr 21;2(1):R31-R50. doi: 10.1530/EO-21-0038. eCollection 2022 Jan.
7
Refusal of Surgery in Pituitary Adenoma Patients: A Population-Based Analysis.垂体腺瘤患者拒绝手术治疗:一项基于人群的分析。
Cancers (Basel). 2022 Oct 30;14(21):5348. doi: 10.3390/cancers14215348.
8
Changes in the Options for Management of Prolactin Secreting Pituitary Adenomas.催乳素分泌型垂体腺瘤治疗选择的变化
J Neurol Surg B Skull Base. 2021 Feb 18;83(Suppl 2):e49-e53. doi: 10.1055/s-0040-1722665. eCollection 2022 Jun.
9
Extra-Pseudocapsular Transsphenoidal Surgery for Microprolactinoma in Women.女性微泌乳素瘤的额外假包膜经蝶窦手术
J Clin Med. 2022 Jul 5;11(13):3920. doi: 10.3390/jcm11133920.
10
C-methionine PET aids localization of microprolactinomas in patients with intolerance or resistance to dopamine agonist therapy.C-蛋氨酸 PET 有助于定位对多巴胺激动剂治疗不耐受或抵抗的患者中的微泌乳素瘤。
Pituitary. 2022 Aug;25(4):573-586. doi: 10.1007/s11102-022-01229-9. Epub 2022 May 24.